GBR_Main_Tile

The Generative Biology Revolution - Q&A
July 20, 2022 @ 2:30 PM Eastern Time

Join us for a Q&A webinar event and explore The Generative Biology Revolution, a special edition podcast series produced by The Scientist’s Creative Services team and brought to you by Amgen, a pioneer in the science of using living cells to make biologic medicines.

Generative biology is a revolutionary approach to drug discovery and development that leverages machine learning and AI to design novel protein therapeutics. It holds the potential to enhance the speed and efficiency of discovery and increase success rates of bringing life-saving medicines to patients who need them most.

In this webinar event, Marissa Mock from Amgen will answer questions that delve deeper into the entire podcast series.

Visit this page to access the Generative Biology Revolution podcast series!

Q&A Speaker

Mock
Marissa Mock, PhD
Director
Generative Biology
Amgen

Sponsor

Amgen.png

Sign up for the Q&A now

TS_Webinar_Amgen_Series 2_Undruggable_IO#403179


Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this Q&A. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these events free of charge for our readers.